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Protein Expression, Purification, and Complex Preparation. All pro-
teins were expressed in E. coli BL21-CodonPlus(DE3)-RIL cells
(Stratagene) and grown in LB media containing appropriate anti-
biotics. Protein expression was induced at OD600 of ≈0.7 with
0.5 mM isopropyl-β-D-thiogalactoside at 18 °C for 12–16 h.
The cells were harvested by centrifugation and lysed with a cell
disruptor (Avestin) in a buffer containing 20 mM Tris, pH 8.0,
500 mM NaCl, 5 mM β-mercaptoethanol (β-ME), 10% (v∕v) gly-
cerol, 0.5 mM phenylmethylsulfonyl fluoride (Sigma), 2 μM bo-
vine lung aprotinin (Sigma), and complete EDTA-free protease
inhibitor cocktail (Roche). After centrifugation at 35;000 × g for
45 min, the cleared lysate was loaded onto a Ni-NTA column
(Qiagen) and eluted via an imidazole gradient. Protein-contain-
ing fractions were pooled, desalted on a HiPrep 26∕20 desalting
column (GE Healthcare) using a buffer containing 20 mM Tris,
pH 8.0, 100 mM NaCl, and 5 mM β-ME, and subjected to clea-
vage with PreScission protease (GE Healthcare) for 24 h at 4 °C.
Following His6-tag removal, the cleaved protein was concen-
trated, and purified over a HiLoad Superdex 200 16∕60 gel filtra-
tion column (GE Healthcare) in a buffer containing 20 mM Tris,
pH 8.0, 100 mM NaCl, and 5 mM dithiothreitol (DTT). For for-
mation of the Nup82NTD•Nup159T•Nup116CTD heterotrimer,
purified Nup116CTD and Nup82NTD•Nup159T were mixed in
an ≈2∶1 molar ratio, incubated for 30 min on ice, and separated
on a HiLoad Superdex 200 16∕60 gel filtration column using a
buffer containing 20 mM Tris, pH 8.0, 100 mM NaCl, and
5 mM DTT. The pure protein fractions were pooled, concen-
trated, snap frozen in liquid nitrogen, and stored at −80 °C.
All experiments conducted with Nup82NTD contained a C396S
mutation that reduced the aggregation behavior of the protein.
The proteins used for gel filtration and isothermal titration calori-
metry were purified as described above with the exception that
the protease cleavage step was omitted. For the purifications
of Nup116CTD, Nup100CTD, and Nup145NCTD, the buffers were
adjusted to pH 7.0. Seleno-L-methionine-labeled proteins were
prepared using a metabolic inhibition protocol (1).
Crystallization, Data Collection, Structure Determination, and Refine-
ment.Crystals of the Nup82NTD•Nup159T•Nup116CTD heterotri-
mer were obtained at 4 °C by vapor diffusion in hanging drops
using 1 μL of the protein complex (10 mg∕mL), 1 μL of a reser-
voir solution consisting of 0.1 M sodium cacodylate, pH 6.6, 26%
(v∕v) PEG 400, 0.1 M Li2SO4, and 0.5 μL of 30% (v∕v) 2,5-hex-
anediol. Plate-shaped crystals grew to their maximum size of
≈80 × 80 × 20 μm3 within two weeks. X-ray diffraction data were
collected at the General Medicine and Cancer Institutes Colla-
borative Access Team (GM/CA CAT) beamline at the Advanced
Photon Source (APS), Argonne National Laboratory (ANL). The
5 μm “minibeam” collimator setup (2) was critical for obtaining
excellent X-ray diffraction data from the twinned crystals. The
structure was solved by single anomalous dispersion (SAD), using
data obtained from seleno-L-methionine-labeled crystals. The
positions of 39 selenium atoms were determined using SHELXD
(3), and phasing was carried out in SHARP (4), followed by den-
sity modification in DM with solvent flattening, NCS averaging,
and histogram matching (5). This protocol yielded an electron
density map of excellent quality. A complete model was built with
the program O (6) and refined with CNS (7). The final model has
good stereochemistry and spans residues 7–452 of Nup82 except
for two short disordered regions (17–22 and 121–122), residues
967–1111 of Nup116, and residues 1433–1458 of Nup159. Details
of the data collection and refinement statistics are summarized in
Table 1.
Analytical Size-Exclusion Chromatography. Protein interaction ex-
periments were carried out on a Superdex 200 10∕300 GL gel
filtration column (GE Healthcare) equilibrated in a buffer
containing 20 mM Tris, pH 8.0, 100 mM NaCl, and 5 mM DTT.
Proteins were mixed at approximately equimolar ratios and incu-
bated for 30 min on ice. Complex formation was monitored by
injection of the preincubated proteins and the individual compo-
nents in isolation. All proteins were analyzed under the same
buffer conditions, and complex formation was confirmed by
SDS-PAGE of the eluted fractions, followed by Coomassie bril-
liant blue staining.
Yeast Strains and In Vivo Analysis. The open reading frames of
Nup82, Nup159, and Nup116 in the Saccharomyces cerevisiae
BY4741 strain were replaced with the kanMX6 cassette by homo-
logous recombination. Due to the lethality of the Nup82 and
Nup159 knockouts, the BY4741 strains were complemented with
pRS416-mCherry constructs carrying the Nop1 promoter and
the full-length proteins. Subsequently, pRS315-GFP constructs
carrying various Nup82, Nup159, and Nup116 variants were in-
troduced in the respective knock-out strains. The pRS416-
mCherry constructs were shuffled out using 5-fluoroorotic acid
(5-FOA) (Zymo Research). The transformants were selected
twice on SD-Leu plates containing 5-FOA to ensure the loss of
the pRS416-mCherry constructs prior to analysis. The details of
the yeast expression constructs are listed in Table S1.
Yeast Growth Analysis and In Vivo Localization. The yeast strains
carrying GFP-Nup82 variants were grown to midlog phase in
SD-Leu media and diluted to 10 million cells∕mL. This stock
was used to generate a 10-fold dilution series, of which 10 μL
were spotted on SD-His-Leu plates and grown at 23 °C, 30 °C,
and 37 °C for 2–3 days.
For localization analysis, the yeast strains carrying GFP-Nup82
variants were grown in SD-Leu media at 30 °C to an OD600 of
≈0.4, then shifted to 37 °C and grown for another 3 h before ana-
lysis. Live cells were analyzed with fluorescence microscopy, using
a Carl Zeiss AxioImagerZ.1 equipped with an AxioCamMRm
camera.
Multiangle Light Scattering. Purified proteins were characterized
by multiangle light scattering following size-exclusion chromato-
graphy (8). Protein at various concentrations (50–100 μM) was
injected onto a Superdex 200 10∕300 GL size-exclusion chroma-
tography column (GE Healthcare) equilibrated in a buffer con-
taining 20 mM Tris-HCl pH 8.0, 100 mM NaCl, and 5 mM DTT.
The chromatography system was connected in series with an 18-
angle light scattering detector (DAWN HELEOS) and refractive
index detector (OptilabrEX) (Wyatt Technology). Data were col-
lected every second at a flow rate of 0.25 mL∕min at 25 °C. Data
analysis was carried out using the program ASTRA, yielding the
molar mass and mass distribution (polydispersity) of the sample.
Isothermal Titration Calorimetry. ITC measurements were per-
formed at 4 °C using a MicroCal VP-ITC calorimeter (MicroCal,
LLC). Protein samples were extensively dialyzed against a buffer
containing 50 mM Tris, pH 8.0, 150 mM NaCl, and 2 mM Tris
(2-carboxyethyl)phosphine (TCEP) and thoroughly degassed.
5–10 μL of 160–200 μM protein was injected into 1.5 mL of
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10 μM protein in the chamber every 120 s. The heat generated
from dilution was subtracted for baseline correction. Baseline-
corrected data were analyzed with ORIGIN software. All experi-
ments were performed at least three times.
Illustration and Figures. The sequence alignments were generated
using ClustalX (9) and colored with Alscript (10). Figures were
generated using PyMOL (www.pymol.org) and the electrostatic
potential was calculated with APBS (11).
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Fig. S1. Structural comparison of Nup116CTD•Nup82NTD and hNup98CTD•6-kDa heterodimers. (A) Ribbon representation of Nup116CTD (green) in complex with
Nup82NTD (yellow). For clarity, only the Nup82NTD 3D4A (or “FGL”) loop is shown. The Nup116CTD β6-αB connector (“K-loop”) that interacts with Nup82NTD is
colored in magenta. (B) Ribbon representation of hNup98CTD (gray), the human homolog of yeast Nup116, in complex with an N-terminal segment of the auto-
proteolytic 6-kDa fragment (orange). (C) Superposition of the Nup116CTD•Nup82NTD and hNup98CTD•6-kDa heterodimers illustrates that the Nup82 FGL loop
binds to Nup116 in the same fashion as the 6-kDa fragment to hNup98, providing a molecular basis for the mutually exclusive binding of Nup82 and 6-kDa
fragment to Nup116 (Fig. 4). (D) Detailed view of the interactions of Nup116CTD with the Nup82NTD FGL loop (yellow) and the 6-kDa YGL loop (orange). For
clarity, hNup98CTD superimposed on Nup116 (green) is omitted.
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Fig. S2. Surface properties of Nup116CTD. (A) Surface rendition of Nup116CTD. The two binding sites for Nup82NTD are colored in yellow and blue, respectively.
The position of the invariant K1063 in the K-loop is indicated. (B) Sequence conservation of Nup116CTD based on the alignment in Fig. S5, mapped onto the
surface and colored in a gradient from white (less than 40% similarity) to yellow (40% similarity) to red (100% identity). (C) Surface rendition of Nup116CTD,
colored according to the electrostatic potential, ranging from red (−10 kBT∕e) to blue (þ10 kBT∕e). While the site with the projecting K-loop is positively
charged, the other site, which accommodates the FGL loop, is primarily hydrophobic.
Fig. S3. Surface properties of Nup82NTD. (A) Surface rendition of Nup82NTD. The Nup116CTD and Nup159T binding sites are colored in green and red, respec-
tively. The positions of D204, F290, and Y295, which disrupt Nup116CTD binding, and of L393, I397, L402, L405, and F410, which interfere with the Nup159T
interaction, are indicated in yellow and orange, respectively. As a reference, the ribbon representation of the heterotrimer is shown on the left. (B) Sequence
conservation of Nup82NTD based on the alignment in Fig. S4, mapped onto the surface and colored in a gradient from white (less than 40% similarity) to yellow
(40% similarity) to red (100% identity). (C) Surface rendition of Nup82NTD, colored according to the electrostatic potential, from red (−10 kBT∕e) to blue
(þ10 kBT∕e). The Nup116 binding site is strongly negatively charged, consistent with the key aspartate residue (D204).
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Fig. S4. Multispecies sequence alignment for the NTD of Nup82 homologs. The numbering below the alignment is relative to S. cerevisiae Nup82. The overall
sequence conservation at each position is shaded in a color gradient from white (less than 40% similarity) to dark red (100% identity) using the Blosum62
weighting algorithm. The secondary structure is indicated above the sequence as blue boxes (α-helices), green arrows (β-strands), gray lines (coil regions), and
gray dots (disordered residues). Residues involved in the interaction with Nup116CTD and Nup159T are indicated by green and magenta dots, respectively. The
positions of D204, F290, and Y295 and of L393, I397, L402, L405, and F410 are labeled below the dots.
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Fig. S5. Multispecies sequence alignment for the CTD of Nup116 homologs. The numbering below the alignment is relative to S. cerevisiae Nup116. The
overall sequence conservation at each position is shaded in a color gradient from white (less than 40% similarity) to dark red (100% identity) using the
Blosum62 weighting algorithm. The secondary structure is indicated above the sequence as blue boxes (α-helices), green arrows (β-strands), and gray dots
(disordered residues). The positions of the invariant K1063 and of A1110 which corresponds to the catalytic S864 in hNup98 are indicated by an asterisk and an
arrowhead, respectively. The two bottom sequences refer to the Nup116 homologs in S. cerevisiae, Nup100 and Nup145N. Consistent with the auto-proteolytic
biogenesis of Nup145N, A1110 of Nup116 is replaced by a catalytic serine residue.
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Fig. S6. Isothermal titration calorimetry (ITC) analysis. (A–C) ITC measurements of Nup82NTD-mediated interactions. The upper parts of the boxes show raw
data, while the lower parts refer to the integrated heat changes, corrected for the heat of dilution, and the fitted curve based on a single-site model. The first
component of the reaction pair is titrated into the second component. (D) Summary of the ITC results. The dissociation constant (Kd ), binding enthalpy (ΔH),
entropy (ΔS), and the stoichiometry (N) were derived by curve fitting using a single-site model. Note that deletion of the 3D4A (“FGL”) loop in Nup82NTD only
leads to a fivefold reduction in affinity for Nup116CTD with respect to wild type and that the presence or absence of Nup159T minimally affects the
Nup82NTD-Nup116CTD interaction.
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Fig. S7. In vivo analysis of Nup116 mutants. (A) Domain organizations of the GFP-labeled Nup116 constructs, colored as in Fig. 1A. (B) Yeast growth analysis
using a nup116Δ strain transformed with the indicated GFP-Nup116 constructs. 10-fold serial dilutions were spotted on SD-Leu plates and grown for 2–3 d at
the indicated temperatures. (C) In vivo localization of GFP-Nup116 at 37 °C. Consistent with the finding that removal of the crystallized fragment, Nup116ΔCTD,
does not abolish nuclear rim staining, an unstructured region upstream is identified as another nuclear envelope targeting region. The scale bars represent
5 μm.
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Fig. S8. In vivo analysis of Nup159 mutants. (A) Domain organizations of GFP-labeled Nup159 constructs, colored as in Fig. 1A. (B) Yeast growth analysis using
a nup159Δ strain transformed with the indicated GFP-Nup159 constructs. 10-fold serial dilutions were spotted on SD-Leu plates and grown for 2–3 d at the
indicated temperatures. (C) In vivo localization of GFP-Nup159 at 37 °C. A mutant lacking the crystallized tail fragment appears identical to wild type, while a
larger C-terminal truncation leads to lethality at 37 °C and mistargeting. The scale bars represent 5 μm.
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Table S1. Bacterial and yeast expression constructs
Bacterial expression constructs*
Protein Residues (mutations) Expression vector Restriction sites 5′, 3′ N-terminal overhang
Nup82NTD† 1-452 pET21a NdeI, XhoI none
Nup82NTD 1-452 pET28a-PreS NdeI, XhoI GPH
Nup82NTD;L393A 1-452 (L393A) pET28a-PreS NdeI, XhoI GPH
Nup82NTD;I397A 1-452 (I397A) pET28a-PreS NdeI, XhoI GPH
Nup82NTD;L402A 1-452 (L402A) pET28a-PreS NdeI, XhoI GPH
Nup82NTD;L405A 1-452 (L405A) pET28a-PreS NdeI, XhoI GPH
Nup82NTD;F410A 1-452 (F410A) pET28a-PreS NdeI, XhoI GPH
Nup82NTD;LILLF 1-452 (L393A, I397A, L402A, L405A, F410A) pET28a-PreS NdeI, XhoI GPH
Nup82NTD;DFY 1-452 (D204A, F290A, Y295A) pET28a-PreS NdeI, XhoI GPH
Nup82NTD;DFY-LILLF 1-452 (DFY and LILLF) pET28a-PreS NdeI, XhoI GPH
Nup116CTD† 967-1,113 pET21a NdeI, XhoI none
Nup116CTD 967-1,113 pET28a-PreS NdeI, NotI GPH
Nup116CTD;K1063A 967-1,113 (K1063A) pET28a-PreS NdeI, NotI GPH
Nup159T† 1,425-1,460 pET28a-PreS NdeI, NotI GPH
SUMO-Nup159T 1,425-1,460 pET28b-SUMO BamHI, HindIII His6-SUMO-tag
Nup159T 1,425-1,460 pETDuet-1 NcoI, NotI GPH
Nup82NTD 1-452 NdeI, XhoI none
SUMO-Nup159T 1,425-1,460 pETDuet-1 NcoI, NotI His6-SUMO-tag
Nup82NTD 1-452 NdeI, XhoI none
Nup159T 1,425-1,460 pETDuet-1 NcoI, NotI GPH
Nup82NTD;Δ3D4A 1-452 (Δ3D4A: Δ172-176) NdeI, XhoI none
Nup159T 1,425-1,460 pETDuet-1 NcoI, NotI GPH
Nup82NTD;D204A 1-452 (D204A) NdeI, XhoI none
Nup159T 1,425-1,460 pETDuet-1 NcoI, NotI GPH
Nup82NTD;F290A 1-452 (F290A) NdeI, XhoI none
Nup159T 1,425-1,460 pETDuet-1 NcoI, NotI GPH
Nup82NTD;Y295A 1-452 (Y295A) NdeI, XhoI none
Nup159T 1,425-1,460 pETDuet-1 NcoI, NotI GPH
Nup82NTD;DFY 1-452 (D204A, F290A, Y295A) NdeI, XhoI none
Nup98CTD 676-863 pET28a-PreS NheI, XhoI GPH
Nup98CTD;K814A 676-863 (K814A) pET28a-PreS NheI, XhoI GPH
Nup98CTDþ6kD 676-920 pET28a-PreS NheI, XhoI GPH
Nup98CTDþ6kD;K814A 676-920 (K814A) pET28a-PreS NheI, XhoI GPH
Nup100CTD 814-959 pET28a-PreS NheI, XhoI GPH
Nup100K910A 814-959 (K910A) pET28a-PreS NheI, XhoI GPH
Nup145NCTD 458-605 pET28a-PreS NheI, XhoI GPH
Nup145NCTD;K558A 458-605 (K558A) pET28a-PreS NheI, XhoI GPH
Yeast expression constructs
Protein Residues (mutations if applicable) Shuffle vector Restriction sites 5′, 3′ Selection
Nup82WT 1-713 pRS416-mCherry NotI, SacII Ura
Nup159WT 1-1,460 pRS416-mCherry NotI, SacII Ura
Nup82WT 1-713 pRS315-GFP XhoI, ApaI Leu
Nup82NTD 1-452 pRS315-GFP XhoI, ApaI Leu
Nup82ΔNTD 453-713 pRS315-GFP XhoI, ApaI Leu
Nup82DFY 1-713 (D204A, F290A, Y295A) pRS315-GFP XhoI, ApaI Leu
Nup82LILLF 1-713 (L393A, I397A, L402A, L405A, F410A) pRS315-GFP XhoI, ApaI Leu
Nup82DFY-LILLF 1-713 (DFY and LILLF) pRS315-GFP XhoI, ApaI Leu
Nup116WT 1-1,113 pRS315-GFP XhoI, ApaI Leu
Nup116FG 1-686 pRS315-GFP XhoI, ApaI Leu
Nup116U 687-967 pRS315-GFP XhoI, ApaI Leu
Nup116CTD 968-1,113 pRS315-GFP XhoI, ApaI Leu
Nup116ΔFG 687-1,113 pRS315-GFP XhoI, ApaI Leu
Nup116ΔCTD 1-967 pRS315-GFP XhoI, ApaI Leu
Nup159WT 1-1,460‡ pRS315-GFP XhoI, ApaI Leu
Nup159-1 1-1,365 pRS315-GFP XhoI, ApaI Leu
Nup159ΔT 1-1,425 pRS315-GFP XhoI, ApaI Leu
*All Nup82NTD constructs used for bacterial expression carry a C396S mutation.
†Constructs were used for crystallization of the Nup82NTD•Nup159T•Nup116CTD heterotrimer.
‡ApaI site in DNA sequence encoding Nup159 was removed by site-directed mutagenesis before treatment with a restriction enzyme pair of XhoI
and ApaI.
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